S&P 500 Industrials Sector SEC Filings — January 12, 2026

13-01-2026

Milestone Pharmaceuticals Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001104659-26-003038, size 190 KB) reporting under Item 8.01 Other Events. No specific details on the event, transaction, financial impacts, or other quantitative data are disclosed in the provided filing summary. Sector is not specified.

13-01-2026

UNITY BANCORP INC /NJ/ filed a Form 8-K on January 13, 2026 (AccNo: 0000920427-26-000004), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a financial results disclosure from the US market with no specific quantitative metrics, transaction values, or detailed financial data provided in the filing summary. Sector is not specified.

13-01-2026

Bitcoin Depot Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001193125-26-011043, Size: 183 KB) reporting Item 5.07: Submission of Matters to a Vote of Security Holders. No specific details on the matters submitted, vote outcomes, or any numerical results are disclosed in the provided filing summary. This appears to be a mandatory single-item disclosure following a shareholder meeting.

13-01-2026

Resolute Holdings Management, Inc. filed an 8-K on January 13, 2026 (AccNo: 0001104659-26-003021), disclosing under Item 1.01 entry into a material definitive agreement, Item 2.01 completion of an acquisition or disposition of assets, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 4.01 changes in certifying accountant, and Item 9.01 financial statements and exhibits. No specific details on deal parties, structure, valuation, or quantitative metrics are provided in the filing summary. Sector is not specified.

13-01-2026

Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001493152-26-001931, Size: 221 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, financial statements, or exhibits are disclosed. Sector is not specified.

13-01-2026

Lafayette Digital Acquisition Corp. I filed an 8-K on January 13, 2026 (AccNo: 0001213900-26-003590), disclosing entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), departure/election of directors/officers and compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws (Item 5.03), other events (Item 8.01), and financial statements/exhibits (Item 9.01). This filing relates to a merger/acquisition event, but specific parties, deal structure, valuation, or quantitative details are NOT_DISCLOSED in the provided summary. Sector is not specified.

13-01-2026

CANNAPHARMARX, INC. filed a Form 8-K on January 13, 2026 (AccNo: 0001654954-26-000277, Size: 247 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on the affected officer position, appointment/resignation status, reasons, or any quantitative data are provided in the filing summary. Sector is not specified.

13-01-2026

Delek US Holdings, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001628280-26-001886, Size: 3 MB) reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a general filing from the US SEC with sector not specified. No core event details, financial metrics, transaction values, or other quantitative data are disclosed in the provided filing summary.

13-01-2026

Bank of New York Mellon Corp filed an 8-K on January 13, 2026 (AccNo: 0001390777-26-000004, size: 8 MB) disclosing financial results under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing focused on financial results. No specific revenue, earnings, transaction values, or other quantitative metrics are mentioned.

13-01-2026

Delta Air Lines, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0000027904-26-000008, Size: 2 MB), reporting entry into a material definitive agreement (Item 1.01), results of operations and financial condition (Item 2.02), and financial statements and exhibits (Item 9.01). No specific details on the agreement, transaction value, financial metrics, or other quantitative data are disclosed in the provided filing summary. This is a multi-item mandatory filing under SEC 8-K requirements.

13-01-2026

Bausch Health Companies Inc. filed an 8-K on January 13, 2026 (AccNo: 0000885590-26-000005, Size: 147 KB) under Items 2.02 (Results of Operations and Financial Condition) and 7.01 (Regulation FD Disclosure). This reports financial results. No specific financial metrics, transaction details, or quantitative data disclosed in the provided filing summary.

13-01-2026

Armata Pharmaceuticals, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001104659-26-003076), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event, transaction details, financial metrics, or numerical values are disclosed in the filing summary. Sector is not specified.

13-01-2026

Traws Pharma, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001104659-26-003071, Size: 231 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the other events, financial statements, exhibits, transactions, or quantitative impacts are disclosed in the provided filing summary. All transaction values, financial metrics, and strategic details are NOT_DISCLOSED.

13-01-2026

Amneal Pharmaceuticals, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001723128-26-000003, Size: 157 KB), disclosing under Item 2.02 Results of Operations and Financial Condition and Item 7.01 Regulation FD Disclosure. This pertains to financial results in the US market, with sector not specified. No specific financial metrics, transaction values, or quantitative data are mentioned in the provided filing summary.

13-01-2026

US BANCORP filed a Form 8-K on January 13, 2026 (AccNo: 0001193125-26-011142, Size: 3 MB), reporting under Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item general filing with no specific transaction details, dollar values, or financial metrics disclosed. Sector not specified.

13-01-2026

Fifth Third Bancorp filed a Form 8-K on January 13, 2026, under Item 8.01 Other Events. Accession Number: 0000035527-26-000011. File size: 752 KB. No details on the specific event, transaction, or financial impacts are disclosed.

13-01-2026

Red Cat Holdings, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0000748268-26-000003, Size: 157 KB), reporting under Item 2.02 for Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, transaction values, or other quantitative financial metrics are disclosed in the provided filing summary. This appears to be a standard voluntary disclosure of financial results.

13-01-2026

DENTSPLY SIRONA Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0000818479-26-000024, Size: 786 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements). The filing also includes Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer, position, appointment/resignation, or reasons are provided.

13-01-2026

Photronics Inc. disclosed an officer change event via Form 8-K filed on January 13, 2026 (AccNo: 0001140361-26-001053, Size: 189 KB), under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position (e.g., CEO, CFO), appointment/resignation status, reasons, or named individuals are provided in the filing summary. Sector is not specified.

13-01-2026

IDEXX Laboratories Inc./DE filed a Form 8-K on January 13, 2026 (AccNo: 0001104659-26-003103, Size: 534 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position, nature of change (appointment or departure), reasons, or any quantitative data are provided in the summary.

13-01-2026

HONG YUAN HOLDING GROUP filed a Form 8-K on January 13, 2026 (AccNo: 0001493152-26-001967, Size: 209 KB) disclosing an officer change under Item 5.02. The filing covers Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the affected officer, position, reason, or terms are provided.

13-01-2026

FIVE STAR BANCORP filed a Form 8-K on January 13, 2026 (AccNo: 0001628280-26-001931, Size: 300 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No details on the core event, transaction, financial impacts, or quantitative data are disclosed in the provided filing summary. Sector is not specified.

13-01-2026

Black Spade Acquisition III Co filed an 8-K on January 13, 2026 (AccNo: 0001104659-26-003253, Size: 155 KB), announcing a merger/acquisition under Item 8.01 Other Events, with Item 9.01 Financial Statements and Exhibits. No details on deal structure, parties involved, valuation, or financial metrics are explicitly stated in the provided filing summary. Sector is not specified.

13-01-2026

Ohio Valley Banc Corp filed a Form 8-K on January 13, 2026, under Item 8.01 Other Events. The filing has accession number 0000894671-26-000002 and size of 147 KB. No specific details on the event, transaction, financial impacts, or other quantitative data are disclosed in the provided filing summary.

13-01-2026

ALPHA MODUS HOLDINGS, INC. filed a Form 8-K on January 13, 2026 (AccNo: 0001493152-26-002012, Size: 251 KB) under Item 7.01 for Regulation FD Disclosure. No specific details, events, transactions, financial metrics, or named entities beyond the filer are disclosed in the provided filing summary. Sector not specified.

13-01-2026

ACADIA PHARMACEUTICALS INC filed a Form 8-K on January 13, 2026 (AccNo: 0001193125-26-011706, Size: 163 KB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results. No specific financial metrics, transaction values, or other quantitative data are disclosed in the provided filing summary.

13-01-2026

TTM Technologies Inc filed a Form 8-K on January 13, 2026, under Item 7.01 Regulation FD Disclosure. The filing has accession number 0001193125-26-011807 and size of 140 KB. No additional details on the disclosure content, events, or financial metrics are provided.

13-01-2026

Solitron Devices Inc filed a Form 8-K on January 13, 2026 (AccNo: 0001437749-26-001187, Size: 246 KB), disclosing Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results with no specific numerical financial metrics, transaction values, or other quantitative details provided in the summary. Sector is not specified.

13-01-2026

Phoenix Education Partners, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001193125-26-011725, Size: 714 KB), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, transaction values, or other quantitative details are disclosed in the provided filing summary. Sector is not specified.

13-01-2026

ALPHATIME ACQUISITION CORP filed an 8-K on January 13, 2026 (AccNo: 0001493152-26-002017, Size: 271 KB), disclosing under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. This is presented as a Merger/Acquisition event with no specific details on parties, structure, valuation, or synergies provided. Sector is not specified.

13-01-2026

Farmers National Banc Corp /OH/ filed an 8-K on January 13, 2026, under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits). AccNo: 0001193125-26-011710, file size 194 KB. No specific events, transactions, financial metrics, or numerical values are disclosed in the provided filing summary.

13-01-2026

Target Hospitality Corp. filed a Form 8-K on January 13, 2026 (AccNo: 0001104659-26-003335, Size: 337 KB), disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, elections or appointments of directors/officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on the officer involved, position, reason for change, or quantitative data were provided.

13-01-2026

TELEPHONE & DATA SYSTEMS INC /DE/ filed an 8-K on January 13, 2026 (AccNo: 0001051512-26-000002, Size: 248 KB) under Item 2.01 announcing the completion of an acquisition or disposition of assets and Item 8.01 for other events. No details on parties involved, deal structure, valuation, strategic rationale, or financial metrics are disclosed. Sector is not specified.

13-01-2026

Aspire Biopharma Holdings, Inc. disclosed an officer change via Form 8-K filed on January 13, 2026 (AccNo: 0001493152-26-002057, Size: 252 KB) under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the affected officer, position, appointment/resignation status, reasons, or compensation are provided in the available information. Sector is not specified.

13-01-2026

GULF ISLAND FABRICATION INC filed a Form 8-K on January 13, 2026 (AccNo: 0001140361-26-001103, Size: 187 KB), reporting Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details, numerical values, transaction sizes, or outcomes are disclosed in the provided filing summary. Sector is not specified.

13-01-2026

Denny's Corp filed a Form 8-K on January 13, 2026 (AccNo: 0001193125-26-011802), reporting under Item 5.07: Submission of Matters to a Vote of Security Holders. No specific vote results, proposals, numerical data, or other details are disclosed in the provided filing information. This is a standard mandatory disclosure following a shareholder meeting.

13-01-2026

Guardian Pharmacy Services, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001193125-26-011826, Size: 4 MB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results with no specific numerical data, transaction details, or strategic information provided in the filing summary. Sector is not specified.

13-01-2026

Crinetics Pharmaceuticals, Inc. filed an 8-K on January 13, 2026 (AccNo: 0001193125-26-011872, Size: 6 MB) reporting under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific financial metrics, transaction values, or other quantitative details are mentioned.

13-01-2026

Laser Photonics Corp disclosed an officer change via Form 8-K filed on January 13, 2026 (AccNo: 0001493152-26-002077, Size: 203 KB). The filing references Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer, position, reason, or compensation provided.

13-01-2026

Belden Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001193125-26-011887, size 178 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the core event, transaction, financial impacts, or exhibits are provided in the filing summary. All quantitative data, named entities, and strategic implications are NOT_DISCLOSED.

13-01-2026

Estrella Immunopharma, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001213900-26-003998, Size: 241 KB), reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. This discloses a delisting event from the US market. Sector not specified.